Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Weinshenker
Brian G
BG
Jacob
Anu
A
D000328:Adult; D001323:Autoantibodies / Q000032:analysis* / Q000097:blood / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000097:blood / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D009900:Optic Nerve / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011237:Predictive Value of Tests; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology / Q000503:physiopathology
D001323:Autoantibodies; D015415:Biomarkers; D007074:Immunoglobulin G